TXMD
NASDAQ · Pharmaceuticals
Therapeuticsmd Inc
$2.10
-0.09 (-4.11%)
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+465.7% upside
Low Target
$7.57
Average Target
$11.88
High Target
$17.16
Current Price
$2.10
Current
$2.10
$2.10
Target
$11.88
$11.88
$7.57
$11.88 avg
$17.16
Scenario Analysis
Bear Case
$7.57
260.5%
Low target
Base Case
$11.88
+465.7%
Avg target
Bull Case
$17.16
+717.1%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$2.95
-28.8% from high
52-Week Low
$0.99
+112.1% from low
Target vs 52W High
$11.88
+302.7% vs high
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 38 | 79% | $1,330.33 | +14.2% |
| RDY | Strong Sell | 45 | 31% | — | +0.0% |
| JNJ | Buy | 31 | 71% | $299.55 | +11.2% |
| MRK | Buy | 36 | 72% | $159.27 | +6.5% |
| PFE | Hold | 36 | 39% | $33.90 | +22.2% |
| BMY | Hold | 35 | 43% | $174.50 | +178.7% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -38.0% |
| ZTS | Hold | 24 | 50% | $209.87 | +194.2% |